(Q35060154)

6 August 2017

Meleagrin, a new FabI inhibitor from Penicillium chryosogenum with at least one additional mode of action (English)

1 reference

6 August 2017

Chang Ji Zheng

1

1 reference

6 August 2017

Mi-Jin Sohn

series ordinal

2

1 reference

6 August 2017

Sangku Lee

series ordinal

3

1 reference

6 August 2017

Won-Gon Kim

series ordinal

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

28 November 2013

1 reference

6 August 2017

1 reference

6 August 2017

8

1 reference

6 August 2017

11

1 reference

6 August 2017

e78922

1 reference

Creative Commons Attribution 3.0 Unported

6 August 2017

start time

28 November 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The MUT056399 inhibitor of FabI is a new antistaphylococcal compound

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Discovery research: the scientific challenge of finding new antibiotics

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Challenges of antibacterial discovery

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

The kalimantacin/batumin biosynthesis operon encodes a self-resistance isoform of the FabI bacterial target

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Triclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Antibacterial leads from microbial natural products discovery.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Vinaxanthone, a new FabI inhibitor from Penicillium sp.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Multi-targeting by monotherapeutic antibacterials.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Platensimycin is a selective FabF inhibitor with potent antibiotic properties

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Inhibiting bacterial fatty acid synthesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Identification of inhibitors of bacterial enoyl-acyl carrier protein reductase

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Antibacterial resistance worldwide: causes, challenges and responses

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Fatty acid biosynthesis as a target for novel antibacterials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Genetic strategies for antibacterial drug discovery

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Triclosan targets lipid synthesis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3842914

Triclosan resistance in clinical isolates of Acinetobacter baumannii.

8 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0078922

Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0078922

Structure-activity studies of the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan: kinetic analysis of mutant FabIs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0078922

Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0078922

Cephalochromin, a FabI-directed antibacterial of microbial origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0078922

Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0078922

Studies on fungal products. VII. The structures of meleagrin and 9-O-p-bromobenzoylmeleagrin.

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.32.94

Identifiers

DOI

10.1371/JOURNAL.PONE.0078922

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p7gaie26snhcdcxcxpnne35dgq

30 July 2022

release_p7gaie26snhcdcxcxpnne35dgq

ADS bibcode

2013PLoSO...878922Z

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p7gaie26snhcdcxcxpnne35dgq

30 July 2022

https://api.fatcat.wiki/v0/release/p7gaie26snhcdcxcxpnne35dgq

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/p7gaie26snhcdcxcxpnne35dgq

1 reference

30 July 2022